ADAP Insider Trading

Insider Ownership Percentage: 12.44%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $80,940.12

Adaptimmune Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Adaptimmune Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adaptimmune Therapeutics Share Price & Price History

Current Price: $1.11
Price Change: Price Decrease of -0.09 (-7.50%)
As of 05/17/2024 01:00 AM ET

This chart shows the closing price history over time for ADAP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Adaptimmune Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2024Adrian RawcliffeCEOSell9,304$0.79$7,350.1614,104View SEC Filing Icon  
1/16/2024Elliot NorryInsiderSell2,287$0.79$1,806.733,363View SEC Filing Icon  
1/16/2024Willaim C. Bertrand, Jr.COOSell4,681$0.79$3,697.997,023View SEC Filing Icon  
1/12/2024Willaim C. Bertrand, Jr.COOSell5,220$0.85$4,437.007,874View SEC Filing Icon  
1/11/2024Adrian RawcliffeCEOSell11,945$0.84$10,033.8018,395View SEC Filing Icon  
1/11/2024Elliot NorryInsiderSell4,009$0.84$3,367.566,104View SEC Filing Icon  
9/1/2023Adrian RawcliffeCEOSell2,403$0.78$1,874.343,449View SEC Filing Icon  
8/1/2023John LungerInsiderSell3,096$0.91$2,817.364,718View SEC Filing Icon  
7/10/2023Garry E MenzelDirectorSell47,702$0.91$43,408.8275,056View SEC Filing Icon  
6/27/2023Adrian RawcliffeCEOSell2,333$0.92$2,146.363,519View SEC Filing Icon  
1/31/2023Cintia PiccinaInsiderSell11,890$1.87$22,234.3019,535View SEC Filing Icon  
1/17/2023Adrian RawcliffeCEOSell10,057$1.86$18,706.0213,351View SEC Filing Icon  
1/17/2023John LungerInsiderSell4,440$1.86$8,258.407,264View SEC Filing Icon  
1/12/2023Adrian RawcliffeCEOSell18,763$1.71$32,084.7324,882View SEC Filing Icon  
1/12/2023Willaim C. Bertrand, Jr.COOSell4,973$1.71$8,503.838,121View SEC Filing Icon  
1/11/2023John LungerInsiderSell3,843$1.75$6,725.256,270View SEC Filing Icon  
1/4/2023Adrian RawcliffeCEOSell5,073$1.69$8,573.376,631View SEC Filing Icon  
1/4/2023John LungerInsiderSell1,100$1.69$1,859.001,725View SEC Filing Icon  
1/4/2023Willaim C. Bertrand, Jr.COOSell3,584$1.69$6,056.965,781View SEC Filing Icon  
9/1/2022Adrian RawcliffeCEOSell2,536$1.97$4,995.923,316View SEC Filing Icon  
8/1/2022John LungerInsiderSell2,983$1.77$5,279.914,829View SEC Filing Icon  
7/5/2022John LungerInsiderSell1,973$1.68$3,314.643,104View SEC Filing Icon  
6/27/2022Adrian RawcliffeCEOSell2,562$1.63$4,176.063,290View SEC Filing Icon  
5/20/2022Gavin WoodCFOBuy39,000$0.29$11,310.0096,000View SEC Filing Icon  
1/18/2022Adrian RawcliffeCEOSell11,096$3.19$35,396.24View SEC Filing Icon  
1/18/2022Elliot NorryInsiderSell2,121$3.19$6,765.99View SEC Filing Icon  
1/18/2022Willaim C. Bertrand, Jr.COOSell4,368$3.19$13,933.92View SEC Filing Icon  
1/12/2022John LungerInsiderSell1,076$3.54$3,809.04View SEC Filing Icon  
1/11/2022Adrian RawcliffeCEOSell14,362$3.56$51,128.72View SEC Filing Icon  
1/11/2022Willaim C. Bertrand, Jr.COOSell3,770$3.56$13,421.20View SEC Filing Icon  
1/4/2022Adrian RawcliffeCEOSell5,532$4.06$22,459.92View SEC Filing Icon  
1/4/2022John LungerInsiderSell1,070$4.06$4,344.20View SEC Filing Icon  
1/4/2022Willaim C. Bertrand, Jr.COOSell3,490$4.06$14,169.40View SEC Filing Icon  
9/1/2021Adrian RawcliffeCEOSell2,782$5.20$14,466.40View SEC Filing Icon  
8/2/2021John LungerInsiderSell2,939$3.58$10,521.62View SEC Filing Icon  
6/28/2021Adrian RawcliffeCEOSell2,794$4.37$12,209.78View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adaptimmune Therapeutics (NASDAQ:ADAP)

31.37% of Adaptimmune Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADAP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Adaptimmune Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2024Baker BROS. Advisors LP10,787,022$17.04M0.2%-1.7%4.370%Search for SEC Filing on Google Icon
5/14/2024Boulder Hill Capital Management LP90,800$0.14M0.1%N/A0.037%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP370,179$0.59M0.0%-27.2%0.150%Search for SEC Filing on Google Icon
5/1/2024Baillie Gifford & Co.15,871,875$25.08M0.0%-0.3%6.431%Search for SEC Filing on Google Icon
4/19/2024JTC Employer Solutions Trustee Ltd26,156$41K0.0%N/A0.003%Search for SEC Filing on Google Icon
4/15/2024Key Client Fiduciary Advisors LLC268,655$0.42M0.2%-20.2%0.027%Search for SEC Filing on Google Icon
4/15/2024Columbia Advisory Partners LLC15,585$25K0.0%N/A0.002%Search for SEC Filing on Google Icon
3/5/2024Twin Focus Capital Partners LLC55,526$44K0.0%N/A0.006%Search for SEC Filing on Google Icon
1/26/2024Baillie Gifford & Co.15,912,140$12.62M0.0%-7.2%1.600%Search for SEC Filing on Google Icon
1/9/2024Key Client Fiduciary Advisors LLC336,620$0.27M0.2%+6.4%0.034%Search for SEC Filing on Google Icon
1/8/2024Harbor Capital Advisors Inc.147,732$0.12M0.0%+9.9%0.015%Search for SEC Filing on Google Icon
11/13/2023Baillie Gifford & Co.17,147,409$13.38M0.0%-0.2%1.725%Search for SEC Filing on Google Icon
10/27/2023Marquette Asset Management LLC99,349$77K0.0%N/A0.010%Search for SEC Filing on Google Icon
10/27/2023Acuitas Investments LLC479,764$0.37M0.2%N/A0.048%Search for SEC Filing on Google Icon
10/20/2023Harbor Capital Advisors Inc.134,415$0.11M0.0%+19.5%0.014%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC50,061$46K0.0%N/A0.005%Search for SEC Filing on Google Icon
9/7/2023MPM Asset Management LLC6,287,101$5.82M2.9%N/A0.632%Search for SEC Filing on Google Icon
8/15/2023Black Maple Capital Management LP69,839$65K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/14/2023X Square Capital LLC26,771$25K0.0%N/A0.003%Search for SEC Filing on Google Icon
8/14/2023CSS LLC IL90,702$84K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/11/2023Artal Group S.A.1,133,775$1.05M0.0%N/A0.114%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC358,010$0.33M0.0%+15.1%0.036%Search for SEC Filing on Google Icon
8/3/2023Oppenheimer & Co. Inc.68,171$63K0.0%N/A0.007%Search for SEC Filing on Google Icon
7/28/2023Baillie Gifford & Co.17,176,135$15.89M0.0%+0.4%1.728%Search for SEC Filing on Google Icon
7/11/2023Harbor Capital Advisors Inc.112,516$0.10M0.0%N/A0.073%Search for SEC Filing on Google Icon
5/17/2023Long Focus Capital Management LLC5,435,439$5.93M0.3%+2.9%3.514%Search for SEC Filing on Google Icon
5/12/2023Long Focus Capital Management LLC2,772,791$3.02M0.3%-47.5%1.793%Search for SEC Filing on Google Icon
5/10/2023Simplify Asset Management Inc.150,000$0.16M0.0%N/A0.097%Search for SEC Filing on Google Icon
5/3/2023Baillie Gifford & Co.17,112,002$18.65M0.0%-0.3%11.064%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC88,234$96K0.0%+193.1%0.057%Search for SEC Filing on Google Icon
4/25/2023Key Client Fiduciary Advisors LLC321,155$0.35M0.2%+8.2%0.208%Search for SEC Filing on Google Icon
2/15/2023Endurant Capital Management LP1,733,236$2.53M1.0%-3.1%1.058%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP28,126$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
2/9/2023HBK Sorce Advisory LLC70,000$65K0.0%+100.0%0.043%Search for SEC Filing on Google Icon
1/17/2023Key Client Fiduciary Advisors LLC296,740$0.43M0.3%-31.9%0.181%Search for SEC Filing on Google Icon
1/11/2023Vigilare Wealth Management28,800$42K0.0%-21.7%0.018%Search for SEC Filing on Google Icon
11/15/2022PFM Health Sciences LP9,320,584$10.02M0.4%+2.3%5.689%Search for SEC Filing on Google Icon
11/15/2022Long Focus Capital Management LLC4,789,490$5.15M0.5%+2.4%2.923%Search for SEC Filing on Google Icon
11/15/2022Endurant Capital Management LP1,788,517$1.92M0.6%-1.9%1.092%Search for SEC Filing on Google Icon
11/14/2022HBK Sorce Advisory LLC35,000$32K0.0%N/A0.021%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP370,288$0.40M0.0%+23.4%0.227%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC40,503$44K0.0%+133.7%0.025%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC340,068$0.37M0.0%+34.6%0.208%Search for SEC Filing on Google Icon
10/27/2022Baillie Gifford & Co.14,664,936$15.76M0.0%-4.3%8.977%Search for SEC Filing on Google Icon
10/12/2022Key Client Fiduciary Advisors LLC435,985$0.47M0.4%+4.8%0.267%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC217,123$0.37M0.0%-59.5%0.134%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.96,110$0.16M0.0%N/A0.059%Search for SEC Filing on Google Icon
8/10/2022Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018%Search for SEC Filing on Google Icon
8/8/2022Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457%Search for SEC Filing on Google Icon
7/11/2022Vigilare Wealth Management41,800$71K0.1%N/A0.026%Search for SEC Filing on Google Icon
5/17/2022Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335%Search for SEC Filing on Google Icon
5/16/2022Eversept Partners LP237,086$0.49M0.0%-32.0%0.151%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP69,612$0.14M0.0%-17.3%0.044%Search for SEC Filing on Google Icon
5/5/2022Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805%Search for SEC Filing on Google Icon
5/5/2022Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011%Search for SEC Filing on Google Icon
4/29/2022Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023%Search for SEC Filing on Google Icon
4/26/2022Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013%Search for SEC Filing on Google Icon
4/21/2022Inspire Investing LLC31,928$66K0.0%+107.4%0.020%Search for SEC Filing on Google Icon
4/21/2022Inspire Advisors LLC45,105$93K0.0%+193.0%0.029%Search for SEC Filing on Google Icon
4/18/2022Key Client Fiduciary Advisors LLC420,447$0.87M0.7%+58.0%0.268%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC136,266$0.51M0.1%N/A0.087%Search for SEC Filing on Google Icon
2/14/2022Eversept Partners LP348,716$1.31M0.1%-21.6%0.223%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP84,129$0.32M0.0%-82.6%0.054%Search for SEC Filing on Google Icon
2/11/2022Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC19,315$72K0.0%-34.0%0.012%Search for SEC Filing on Google Icon
2/7/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$0.28M0.0%+13.6%0.044%Search for SEC Filing on Google Icon
2/3/2022Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016%Search for SEC Filing on Google Icon
2/3/2022Inspire Investing LLC15,393$58K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/27/2022Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007%Search for SEC Filing on Google Icon
1/20/2022Baillie Gifford & Co.13,756,352$51.59M0.0%+7.3%8.807%Search for SEC Filing on Google Icon
12/1/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%Search for SEC Filing on Google Icon
11/18/2021Personal CFO Solutions LLC36,388$0.19M0.0%+19.7%0.023%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC349,683$1.81M0.0%-1.7%0.224%Search for SEC Filing on Google Icon
11/16/2021ACT Capital L.L.C.90,000$0.47M0.2%N/A0.058%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC31,881$0.17M0.0%+127.8%0.020%Search for SEC Filing on Google Icon
11/16/2021Toroso Investments LLC10,554$55K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC1,584,849$8.19M0.0%+70.3%1.015%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.76,300$0.39M0.0%-96.3%0.049%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC57,953$0.30M0.0%+485.4%0.037%Search for SEC Filing on Google Icon
11/15/2021Man Group plc148,305$0.77M0.0%+44.2%0.095%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al16,004$83K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP2,189,788$11.32M0.2%+41.7%1.403%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP1,553,800$8.03M0.0%N/A0.995%Search for SEC Filing on Google Icon
11/15/2021Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%Search for SEC Filing on Google Icon
11/15/2021Wealthspire Advisors LLC11,750$61K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/15/2021Virtus ETF Advisers LLC47,350$0.25M0.1%-5.0%0.030%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP444,887$2.30M0.2%N/A0.285%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP484,782$2.51M0.3%-5.6%0.311%Search for SEC Filing on Google Icon
11/12/2021Trexquant Investment LP23,609$0.12M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/12/2021Blueshift Asset Management LLC11,933$62K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/10/2021US Bancorp DE5,729$29K0.0%+403.0%0.004%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.330,378$1.71M0.0%-13.3%0.212%Search for SEC Filing on Google Icon
11/10/2021KBC Group NV45,900$0.24M0.0%+77.2%0.029%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.41,991$0.22M0.0%-15.9%0.027%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC740,915$3.83M0.0%-9.5%0.475%Search for SEC Filing on Google Icon
11/10/2021Healthcare of Ontario Pension Plan Trust Fund60,300$0.31M0.0%-94.1%0.039%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Adaptimmune Therapeutics logo
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Read More on Adaptimmune Therapeutics

Today's Range

Now: $1.11
Low: $1.10
High: $1.18

50 Day Range

MA: $1.27
Low: $0.90
High: $1.59

52 Week Range

Now: $1.11
Low: $0.42
High: $2.05

Volume

1,056,715 shs

Average Volume

908,377 shs

Market Capitalization

$273.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.44

Who are the company insiders with the largest holdings of Adaptimmune Therapeutics?

Adaptimmune Therapeutics' top insider shareholders include:
  1. Gavin Wood (CFO)
  2. Garry E Menzel (Director)
  3. Adrian Rawcliffe (CEO)
  4. Cintia Piccina (Insider)
  5. William C Bertrand Jr (COO)
  6. John Lunger (Insider)
  7. Elliot Norry (Insider)
Learn More about top insider investors at Adaptimmune Therapeutics.

Who are the major institutional investors of Adaptimmune Therapeutics?

Adaptimmune Therapeutics' top institutional shareholders include:
  1. Baillie Gifford & Co. — 6.43%
  2. Baker BROS. Advisors LP — 4.37%
  3. GSA Capital Partners LLP — 0.15%
  4. Key Client Fiduciary Advisors LLC — 0.03%
  5. Boulder Hill Capital Management LP — 0.04%
  6. JTC Employer Solutions Trustee Ltd — 0.00%
Learn More about top institutional investors of Adaptimmune Therapeutics stock.

Which institutional investors are selling Adaptimmune Therapeutics stock?

In the last quarter, ADAP stock was sold by these institutional investors:
  1. Baker BROS. Advisors LP
  2. GSA Capital Partners LLP
  3. Key Client Fiduciary Advisors LLC
  4. Baillie Gifford & Co.
During the last year, company insiders that have sold Adaptimmune Therapeutics company stock include:
  1. Gavin Wood (CFO)
  2. Garry E Menzel (Director)
  3. Adrian Rawcliffe (CEO)
  4. Cintia Piccina (Insider)
  5. William C Bertrand Jr (COO)
Learn More investors selling Adaptimmune Therapeutics stock.

Which institutional investors are buying Adaptimmune Therapeutics stock?

During the last quarter, ADAP stock was acquired by institutional investors including:
  1. Boulder Hill Capital Management LP
  2. JTC Employer Solutions Trustee Ltd
  3. Columbia Advisory Partners LLC